TEDCO
VC Fund
Columbia, United States
TEDCO is an independent organization that strives to be Maryland’s lead source for entrepreneurial business assistance and seed funding for the development of startup companies in Maryland’s innovation economy.
- Total investments:
- 343
- Last investment:
- Lead investor:
- 70%
Last updated:
For AI agents: llms.txt
Industries TEDCO invests in
Stages TEDCO invests in
Countries TEDCO invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 22 contacts → | |||
Round size
- Seed
- $100k–$2.5M
- Grant
- $54k–$1M
- Pre-Seed
- $25k–$900k
Investment Focus
Industry
- Health Care 58 (17%)
- Software 47 (14%)
- Biotechnology 34 (10%)
- Information Technology 33 (10%)
- Medical 32 (9%)
Stage
- Seed 100 (29%)
- Grant 77 (22%)
- Pre-Seed 44 (13%)
- Non-equity Assistance 18 (5%)
- Venture - Series Unknown 16 (5%)
Country
- United States 249 (73%)
- Canada 1 (0%)
- Colombia 1 (0%)
- United Kingdom 1 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Graham Dodge
Vice President
|
Vice President | Total investments: 9 | Find email | |
Jack Schammel
Assistant Director
|
Assistant Director | Total investments: 0 | Find email | |
Michael Ross
Summer Associate
|
Summer Associate | Total investments: 0 | Find email | |
Abishek Kulshreshtha
Executive Director
|
Executive Director | Total investments: 0 | Find email | |
Anne Artmeier Balduzzi
Managing Director, Entrepreneur and Ecosystem Empowerment
|
Managing Director, Entrepreneur and Ecosystem Empowerment | Total investments: 3 | Find email | |
| See all 22 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Revelo is an off-the-shelf product to capture, analyze, and report on multiple metrics originating from varied data sources, which can then be collated, harmonized, and analyzed for decision-making. Their products includes iaccessible, e-508, e-translators, and e-editor. | $300K / Pre-Seed / Oct 14, 2026 | ||
| Syntes AI is building the enterprise execution platform that enables AI to move from insight to action. While much of the market has focused on chat-based assistants and copilots, Syntes delivers the missing execution layer required to operationalize AI inside complex enterprises. At the core of the platform is a Live Context Graph that continuously reflects enterprise data, relationships, and operational state across systems. This shared context grounds analytics, machine learning, and AI-driven workflows in real business conditions, reducing errors, improving explainability, and enabling controlled execution across ERP, CRM, and operational platforms. Syntes helps organizations unify fragmented data, reason across silos, and automate high-value decisions and processes with human oversight. By providing a trusted foundation for analytics and execution, Syntes enables enterprises in Retail, Consumer Brands, Financial Services, and the Public Sector to deploy AI at scale, safely, predictably, and with measurable impact. | $250K / Pre-Seed / Sep 16, 2026 | ||
| Astek Diagnostics is building a platform (Eugris) that guides physicians in prescribing appropriate antibiotics for patients with bacterial sepsis in one hour. It is done by detecting the oxygen consumption of the bacteria | $750K / Seed / Aug 25, 2026 | ||
| Balance Theory provides a knowledge sharing and collaboration platform purpose-built for cybersecurity. | $19M / Series A / Jul 31, 2026 | ||
| CurieDx provides an app that screens for strep throat using smartphone images. The app is designed for both medical and home use. Clinicians can use the AI tool to support remote strep throat screening in urgent care or telehealth settings. Patients can use the app at home to check for strep throat and share results with a doctor. The serviceconnects users with telehealth partners for medical care. The app is based on research developed by medical experts. | $200K / Seed / Jul 21, 2026 | ||
| BC3 Technologies is a company with the heart of Baltimore at it’s roots. The company was built on the idea that there needed to be a change in the medical industry regarding arterial bleeding. In the pursuit of solving this major international problem, passionate like-minded individuals began working together to help. Endeavoring to save countlesslives, BC3 Technologies advanced forward. And with the help of Dr. Freier and Dr. Montenegro, the vision of S.E.A.L. became a reality. | $200K / Venture - Series Unknown / Jul 15, 2026 | ||
| Alchemity develops modular, turnkey reactor systems that convert greenhouse gases and underutilized resources into carbon-neutral fuels and high-value chemicals. The company applies ion-conducting ceramic and solid oxide technologies to transform methane and other inputs into value-added products. Its systems target applications in clean fuelsproduction and chemical manufacturing where circular resource use is a priority. Alchemity engages partners for sales, investment, technical support, and collaboration on commercialization projects. | $250K / Seed / Jul 09, 2026 | ||
| Our mission is to develop a superior vaccine platform to improve clinical outcomes for cancer patients | $250K / Jul 07, 2026 | ||
| Ion Storage Systems is focused on developing the most energy dense, safest batteries that can be deployed in any environment. Breakthroughs in solid state battery technology have led to a battery that meets the mission critical needs for the defense and aerospace industries; and safer more efficient for consumer electronics and electric vehicles. | $2M / Venture - Series Unknown / Jun 02, 2026 | ||
| 1104Health is a digital health company that democratizes cancer care for all with tech, healthcare, and research.Their vision is to utilize AI technology to fulfill the unmet need of efficiently connecting cancer patients with specialists and clinical trials. By doing so, they aim to provide all cancer patients with the necessary resources andsupport to persevere in their battle against cancer until a cure is found. | $225K / Seed / May 28, 2026 | ||
| See all 343 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does TEDCO invest in?
TEDCO invests primarily in Health Care, Software and Biotechnology startups, most often at Seed and Grant stage. Most of the 343 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does TEDCO invest in?
TEDCO typically joins rounds of $100k–$2.5M at Seed, $54k–$1M at Grant and $25k–$900k at Pre-Seed. These are whole funding-round sizes, not TEDCO's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds TEDCO took part in.
How do I contact TEDCO?
Public channels for TEDCO include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at TEDCO?
The team at TEDCO includes Graham Dodge (Vice President), Jack Schammel (Assistant Director) and Michael Ross (Summer Associate), among 22 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
